IRulya Therapeutics (IRLA) Common Equity (2018 - 2026)
IRulya Therapeutics' Common Equity came in at -$35.32 million for Q2 2026, compared with $11.74 million a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics' Common Equity was -$35.71 million.
- Going back by year, Common Equity was $30.15 million in FY2024 (-64.6%), $85.08 million in FY2023 (-15.4%), $100.59 million in FY2022 (-15.2%) and $118.59 million in FY2021 (-31.2%).
- The five-year range for quarterly Common Equity is -$35.71 million (Q4 2025) to $132.65 million (Q3 2021).
- Over the past five years, the year-over-year decline in Common Equity ranged from 15.2% (Q4 2022) to 97.6% (Q3 2025).
- Business Quant data shows IRLA's Common Equity at $15.67 million (Q1 2026), -$35.71 million (Q4 2025) and $1.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | -35.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.32 Mn |
| Mar 31, 2026 | 15.67 Mn |
| Dec 31, 2025 | -35.71 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 11.74 Mn |
| Mar 31, 2025 | 18.58 Mn |
| Dec 31, 2024 | 30.15 Mn |
| Sep 30, 2024 | 44.93 Mn |
| Jun 30, 2024 | 46.97 Mn |
| Mar 31, 2024 | 74.18 Mn |
| Dec 31, 2023 | 85.08 Mn |
| Sep 30, 2023 | 83.13 Mn |
| Jun 30, 2023 | 86.88 Mn |
| Mar 31, 2023 | 90.20 Mn |
| Dec 31, 2022 | 100.59 Mn |
| Sep 30, 2022 | 104.53 Mn |
| Jun 30, 2022 | 111.53 Mn |
| Mar 31, 2022 | 106.38 Mn |
| Dec 31, 2021 | 118.59 Mn |
| Sep 30, 2021 | 132.65 Mn |
API Access
IRulya Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();